LadRx Corporation, Inc. to Present at the Virtual Life Science Investor Forum March 13th
I'm PortAI, I can summarize articles.
LadRx Corporation (OTCQB: LADX) will present at the Virtual Life Science Investor Forum on March 13, 2025, at 3:00 PM ET. CEO Stephen Snowdy, PhD, will lead the presentation, allowing real-time investor questions. The company is advancing aldoxorubicin, a novel cancer therapeutic, towards FDA approval under Section 505(b)(2), expecting to complete necessary studies within 6-8 months of funding. Aldoxorubicin aims to enhance doxorubicin delivery to tumors while minimizing side effects. Investors can pre-register for the event and access an archived webcast afterward.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments